Home Data Calendar Blog

MRSN

Tables

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 NA NA NA

Weighted Average Number Of Diluted Shares Outstanding 120.52 115.61 107.51 NA 97.64 95.76 79.93 NA 71.75 69.62 68.99 NA 68.42 60.75 47.99 47.89 47.83 47.71 31.46 NA NA 22.97 22.82 NA NA NA NA 2.65 1.28 1.25 1.24

Weighted Average Number Of Shares Outstanding Basic 120.52 115.61 107.51 NA 97.64 95.76 79.93 NA 71.75 69.62 68.99 NA 68.42 60.75 47.99 47.89 47.83 47.71 30.30 NA NA 22.97 22.82 NA NA NA NA 1.29 1.28 1.25 1.24

Earnings Per Share Basic -0.35 -0.47 -0.52 -0.43 -0.61 -0.55 -0.59 -0.68 -0.63 -0.59 -0.50 -0.42 -0.33 -0.33 -0.35 -0.34 -0.35 -0.36 0.72 NA NA -0.54 -0.54 NA NA NA NA 0.07 -4.56 -3.00 -4.31

Earnings Per Share Diluted -0.35 -0.47 -0.52 -0.43 -0.61 -0.55 -0.59 -0.68 -0.63 -0.59 -0.50 -0.42 -0.33 -0.33 -0.35 -0.34 -0.35 -0.36 0.70 NA NA -0.54 -0.54 NA NA NA NA 0.07 -4.56 -3.00 -4.31

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Revenue From Contract With Customer Excluding Assessed Tax 7.70 10.65 7.80 14.69 5.57 4.28 2.04 0.01 0.01 0.01 0.01 0.01 0.01 0.80 0.01 0.04 0.84 0.20 41.03 1.19 2.15 4.19 3.06 3.26 6.27 3.73 4.29 12.00 3.26 6.21 3.70

Revenues 7.70 10.65 7.80 14.69 5.57 4.28 2.04 0.01 0.01 0.01 0.01 0.01 0.01 0.80 0.01 0.04 0.84 0.20 41.03 1.19 2.15 4.19 3.06 3.26 6.27 3.73 4.29 12.00 3.26 6.21 3.70

Operating Expenses 51.64 67.16 65.60 60.51 65.21 56.03 48.59 48.04 45.40 40.84 34.62 28.77 22.43 20.58 17.16 16.64 18.14 17.96 19.59 23.97 19.56 16.89 15.83 17.61 14.32 12.83 12.40 10.79 9.15 10.00 9.06

Research And Development Expense 30.53 48.97 47.27 45.71 50.64 41.23 35.81 37.37 35.27 31.95 27.41 22.86 16.55 15.41 12.22 12.43 13.70 13.77 15.14 19.82 15.18 12.66 12.26 14.55 11.41 10.63 10.11 8.85 7.55 8.17 7.44

General And Administrative Expense 12.89 18.19 18.33 14.80 14.57 14.80 12.78 10.67 10.12 8.88 7.21 5.91 5.88 5.17 4.94 4.21 4.44 4.19 4.44 4.15 4.38 4.23 3.57 3.06 2.90 2.20 2.30 1.94 1.60 1.83 1.62

Interest Expense 1.02 1.02 0.98 0.96 0.88 0.76 0.72 0.98 0.10 0.10 0.09 0.09 0.09 0.09 0.09 0.09 0.11 0.04 NA NA NA NA NA NA NA NA NA NA NA NA NA

Interest Expense Debt NA NA NA NA NA NA 0.70 0.53 0.09 0.09 0.09 0.17 0.06 0.05 0.05 0.15 0.05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Interest Paid Net 0.87 0.85 0.79 0.72 0.65 0.57 0.53 0.24 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.04 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Allocated Share Based Compensation Expense 4.00 6.64 6.41 5.31 5.38 5.35 5.49 4.86 4.93 4.58 4.04 1.99 1.92 1.66 1.61 1.26 1.28 1.16 1.16 1.07 1.05 0.96 0.74 0.38 0.37 0.35 0.26 0.23 0.20 0.13 NA

Profit Loss -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 -8.95 -8.06 1.26 -5.84 NA NA

Other Comprehensive Income Loss Net Of Tax NA NA 0.16 NA NA -0.13 NA NA NA NA NA NA -0.00 0.01 -0.03 -0.00 0.02 0.01 0.01 0.03 0.05 0.07 -0.01 NA NA NA NA NA NA NA NA

Net Income Loss -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 -8.95 -8.06 1.26 -5.84 -3.77 -5.36

Comprehensive Income Net Of Tax -41.61 -54.37 -56.00 -44.84 -59.92 -52.34 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.78 -16.95 -16.25 -16.77 -17.06 21.91 -22.40 -17.02 -12.28 -12.42 -14.10 -7.74 -8.96 -8.06 1.26 -5.84 -3.77 NA

Net Income Loss Available To Common Stockholders Basic -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 -8.95 -8.06 0.09 -5.84 -3.77 -5.36

Net Income Loss Available To Common Stockholders Diluted -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Assets 262.90 311.00 296.19 334.34 314.85 252.35 258.27 206.11 217.59 253.69 247.91 273.40 290.13 310.52 95.86 107.54 121.66 139.38 149.39 78.50 94.38 106.91 115.75 130.72 142.92 85.22 NA 105.09 NA NA NA

Liabilities 210.71 221.20 231.90 242.28 224.62 118.32 117.74 84.37 62.04 58.17 49.97 45.31 36.82 36.95 32.77 29.22 28.61 30.87 25.32 69.71 64.52 NA NA 60.72 NA NA NA NA NA NA NA

Liabilities And Stockholders Equity 262.90 311.00 296.19 334.34 314.85 252.35 258.27 206.11 217.59 253.69 247.91 273.40 290.13 310.52 95.86 107.54 121.66 139.38 149.39 78.50 94.38 106.91 115.75 130.72 142.92 85.22 NA 105.09 NA NA NA

Stockholders Equity 52.20 89.80 64.29 92.06 90.23 134.03 140.53 121.74 155.55 195.51 197.94 228.09 253.31 273.56 63.09 78.32 93.05 108.51 124.07 8.79 29.85 45.69 56.55 69.99 83.64 -71.66 NA -55.62 NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Assets Current 249.74 297.09 281.81 319.22 300.04 237.08 241.47 188.90 199.36 233.43 231.95 258.58 274.93 294.90 80.29 101.33 114.70 131.62 141.07 74.31 90.05 102.19 111.36 117.54 136.72 79.56 NA 102.17 NA NA NA

Cash And Cash Equivalents At Carrying Value 186.28 128.73 122.83 128.88 184.08 135.34 230.06 177.95 191.71 227.39 228.43 255.09 270.94 288.38 60.45 62.35 58.20 116.21 137.28 59.63 61.60 51.14 32.35 26.59 50.76 33.05 88.52 100.30 86.84 91.72 NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 186.76 129.21 123.30 129.36 184.56 135.82 230.53 178.43 192.19 227.87 228.75 255.41 271.26 288.70 60.77 62.67 58.52 116.58 137.65 60.01 61.98 51.51 32.73 26.96 51.13 33.42 88.89 100.67 NA NA NA

Accounts Receivable Net Current NA NA NA 30.00 NA NA NA NA NA NA NA NA NA NA NA NA 0.30 0.29 0.47 0.46 0.59 1.68 0.29 0.78 0.73 0.51 NA 1.05 NA NA NA

Prepaid Expense And Other Assets Current 8.75 10.50 7.89 8.51 9.91 11.95 11.41 10.95 7.65 6.04 3.52 3.49 4.00 3.53 1.87 1.54 2.40 3.15 3.33 3.71 3.40 4.00 3.11 2.02 2.62 1.81 NA 0.82 NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Property Plant And Equipment Net NA NA NA 3.98 NA NA NA 1.97 NA NA NA 1.73 1.70 1.77 1.98 2.16 2.45 2.75 2.87 2.69 2.52 2.75 2.59 2.32 2.33 2.37 NA 2.48 NA NA NA

Other Assets Noncurrent 0.48 0.52 0.59 0.66 0.62 0.72 2.25 2.36 2.93 4.61 3.52 2.15 2.15 2.10 1.45 1.45 1.45 1.50 1.50 1.50 1.80 1.97 1.80 0.37 0.38 3.28 NA 0.43 NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Liabilities Current 67.93 74.92 83.40 91.53 88.79 71.47 56.46 47.52 44.02 40.47 34.92 30.00 21.07 22.42 17.49 24.07 22.38 23.92 22.59 69.42 31.44 31.88 29.34 31.88 24.51 31.43 NA 28.39 NA NA NA

Accounts Payable Current 12.95 16.92 18.16 13.95 13.73 8.16 9.78 12.32 5.87 10.65 11.74 8.34 4.53 7.16 4.60 7.30 7.30 6.52 6.96 10.73 6.73 4.16 2.52 3.07 3.21 1.86 NA 2.07 NA NA NA

Other Accrued Liabilities Current 0.52 0.52 0.41 0.64 0.29 0.25 0.49 0.28 0.11 0.12 0.13 0.07 0.07 0.06 0.05 0.04 0.23 0.23 0.37 0.45 0.55 0.50 0.58 0.23 0.34 0.18 NA 0.15 NA NA NA

Accrued Liabilities Current 29.32 33.47 32.59 43.18 41.20 34.26 27.48 28.72 31.71 23.38 17.50 16.15 11.17 8.37 5.68 8.99 8.04 9.76 7.94 12.38 10.51 8.49 5.91 6.94 4.61 4.50 NA 3.43 NA NA NA

Other Liabilities Current 0.94 1.01 0.98 0.99 0.24 0.23 0.23 0.24 0.25 0.13 0.13 0.09 0.09 0.09 0.09 0.09 0.09 0.08 0.08 0.13 NA NA NA NA NA NA NA NA NA NA NA

Contract With Customer Liability Current 21.59 20.50 28.77 30.61 30.92 26.23 16.58 3.94 3.96 3.97 3.98 3.99 4.00 4.01 4.80 4.82 4.65 5.48 5.60 46.20 14.15 19.22 20.90 21.64 NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Long Term Debt 25.16 25.08 25.00 24.93 24.85 24.78 24.70 24.63 5.08 4.87 5.01 4.98 4.94 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Long Term Debt Noncurrent 25.00 25.00 25.00 24.93 25.00 25.00 25.00 24.63 5.20 5.03 5.20 4.98 4.94 3.26 3.73 4.20 4.67 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Liabilities Noncurrent 0.07 0.08 0.14 0.20 0.27 0.33 0.39 0.97 1.03 0.29 0.32 0.17 0.20 0.23 0.25 0.28 0.30 0.32 0.35 0.28 NA NA NA NA NA NA NA NA NA NA NA

Operating Lease Liability Noncurrent 6.05 6.93 7.77 8.57 9.29 10.06 10.57 11.25 11.90 12.54 9.73 10.16 10.61 11.04 11.29 0.68 1.26 1.82 2.38 NA NA NA NA NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Stockholders Equity 52.20 89.80 64.29 92.06 90.23 134.03 140.53 121.74 155.55 195.51 197.94 228.09 253.31 273.56 63.09 78.32 93.05 108.51 124.07 8.79 29.85 45.69 56.55 69.99 83.64 -71.66 NA -55.62 NA NA NA

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 NA NA NA

Additional Paid In Capital Common Stock 859.00 855.00 775.12 746.89 700.22 684.11 638.25 572.21 557.04 551.53 513.04 508.50 504.88 502.64 272.39 270.66 269.14 267.83 266.33 172.97 171.63 170.45 169.02 168.02 167.56 4.53 NA 3.55 NA NA NA

Retained Earnings Accumulated Deficit -806.82 -765.16 -710.85 -654.69 -609.77 -549.96 -497.74 -450.48 -401.50 -356.02 -315.11 -280.42 -251.57 -229.09 -209.30 -192.37 -176.13 -159.34 -142.26 -164.17 -141.73 -124.67 -112.31 -97.88 -83.91 -76.18 NA -59.17 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax 0.00 -0.05 0.01 -0.15 -0.23 -0.13 NA NA NA NA NA NA NA 0.00 -0.00 0.03 0.03 0.01 NA -0.01 -0.04 -0.09 -0.16 -0.15 NA NA NA NA NA NA NA

Stock Issued During Period Value New Issues NA 71.88 21.80 NA 10.63 39.90 60.46 NA NA 33.29 NA NA NA NA NA NA NA NA 92.16 NA NA NA NA NA NA NA NA NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.00 6.64 6.41 NA 5.38 5.35 5.49 NA 4.93 4.58 4.04 1.99 1.92 1.66 1.61 1.26 1.28 1.16 1.16 1.13 1.05 0.96 0.74 NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Net Cash Provided By Used In Operating Activities -46.08 -61.83 -29.00 -51.23 54.60 -44.78 -7.96 -42.40 -36.10 -34.47 -27.02 -17.32 -20.20 -15.94 -21.25 -12.58 -16.28 -14.20 -24.69 -15.90 -10.47 -11.45 -17.39 -11.00 -11.08 -9.69 -10.91 13.18 -4.78 NA NA

Net Cash Provided By Used In Investing Activities 103.78 -5.44 1.40 -45.43 -16.49 -90.47 -0.33 -0.15 -0.05 -0.33 -0.11 -0.19 2.81 14.97 19.43 16.50 -41.77 -12.15 10.13 13.72 20.73 29.85 22.90 -13.19 -41.85 -44.11 -0.47 0.25 -0.06 NA NA

Net Cash Provided By Used In Financing Activities -0.15 73.18 21.55 41.46 10.64 40.53 60.39 28.80 0.46 33.92 0.47 1.67 -0.05 228.89 -0.09 0.23 -0.01 5.28 92.20 0.21 0.21 0.39 0.26 0.02 70.64 -1.66 -0.40 0.02 -0.04 NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Net Cash Provided By Used In Operating Activities -46.08 -61.83 -29.00 -51.23 54.60 -44.78 -7.96 -42.40 -36.10 -34.47 -27.02 -17.32 -20.20 -15.94 -21.25 -12.58 -16.28 -14.20 -24.69 -15.90 -10.47 -11.45 -17.39 -11.00 -11.08 -9.69 -10.91 13.18 -4.78 NA NA

Net Income Loss -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 -8.95 -8.06 1.26 -5.84 -3.77 -5.36

Profit Loss -41.66 -54.31 -56.16 -44.92 -59.81 -52.22 -47.26 -48.98 -45.47 -40.91 -34.69 -28.84 -22.49 -19.79 -16.93 -16.25 -16.79 -17.07 21.90 -22.43 -17.07 -12.35 -12.40 -13.97 -7.73 -8.95 -8.06 1.26 -5.84 NA NA

Depreciation Depletion And Amortization 0.43 0.32 0.32 0.28 0.21 0.23 0.20 0.21 0.21 0.21 0.23 0.26 0.26 0.25 0.25 0.28 0.31 0.32 0.34 0.35 0.34 0.31 0.26 0.26 0.23 0.23 0.21 0.21 0.18 NA NA

Increase Decrease In Accounts Receivable 0.00 0.00 -30.00 NA NA NA NA NA NA NA NA NA NA NA NA -0.30 0.01 -0.18 0.01 -0.13 -1.09 1.39 -0.50 0.05 0.22 -0.20 -0.34 0.24 -1.60 NA NA

Increase Decrease In Accounts Payable -4.00 -1.39 4.73 -0.21 5.54 -1.86 -2.52 2.91 -4.70 -1.15 3.42 3.71 -2.39 2.32 -2.69 -0.01 0.81 -0.47 -3.44 3.76 2.64 1.59 -0.62 0.22 1.32 -0.15 -0.05 0.42 -0.22 NA NA

Share Based Compensation 4.00 6.64 6.41 5.31 5.38 5.35 5.49 4.86 4.93 4.58 4.04 1.99 1.92 1.66 1.61 1.26 1.28 1.16 1.16 1.13 1.05 0.96 0.74 0.43 0.37 0.35 0.26 0.23 0.20 NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Net Cash Provided By Used In Investing Activities 103.78 -5.44 1.40 -45.43 -16.49 -90.47 -0.33 -0.15 -0.05 -0.33 -0.11 -0.19 2.81 14.97 19.43 16.50 -41.77 -12.15 10.13 13.72 20.73 29.85 22.90 -13.19 -41.85 -44.11 -0.47 0.25 -0.06 NA NA

Payments To Acquire Property Plant And Equipment 0.47 0.40 0.91 0.79 0.43 0.66 0.33 0.15 0.05 0.33 0.11 0.19 0.20 0.03 0.07 0.00 0.03 0.21 0.37 0.28 0.27 0.55 0.27 0.71 0.10 -0.14 0.47 -0.25 0.06 NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Net Cash Provided By Used In Financing Activities -0.15 73.18 21.55 41.46 10.64 40.53 60.39 28.80 0.46 33.92 0.47 1.67 -0.05 228.89 -0.09 0.23 -0.01 5.28 92.20 0.21 0.21 0.39 0.26 0.02 70.64 -1.66 -0.40 0.02 -0.04 NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31

Revenues 7.70 10.65 7.80 14.69 5.57 4.28 2.04 0.01 0.01 0.01 0.01 0.01 0.01 0.80 0.01 0.04 0.84 0.20 41.03 1.19 2.15 4.19 3.06 3.26 6.27 3.73 4.29 12.00 3.26 6.21 3.70

Revenue From Contract With Customer Excluding Assessed Tax 7.70 10.65 7.80 14.69 5.57 4.28 2.04 0.01 0.01 0.01 0.01 0.01 0.01 0.80 0.01 0.04 0.84 0.20 41.03 1.19 2.15 4.19 3.06 3.26 6.27 3.73 4.29 12.00 3.26 6.21 3.70

A2022 Merck Research Collaboration License Agreement 2.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

G S K Agreement 0.50 NA NA NA 0.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Limited Services, Janssen Agreement NA NA NA NA NA 4.30 1.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Development Milestone Achieved, Collaboration And Commercial License Agreement Asana Bio Sciences 0.00 0.00 2.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Limited Services, Collaboration And Commercial License Agreement Asana Bio Sciences NA NA NA 0.00 0.00 0.00 0.30 NA NA NA NA NA NA 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.59 0.00 NA NA NA NA NA NA NA NA NA

A2022 Merck Research Collaboration License Agreement NA 2.50 3.10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

G S K Agreement NA 0.60 0.70 NA 0.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Janssen Agreement NA 7.50 1.50 13.30 4.90 4.30 1.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Net Income Loss

Expenses

Interest Expense

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Property Plant And Equipment Net

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Other Assets Noncurrent

Liabilities

Operating Lease Liability

Current Liabilities

Other Accrued Liabilities Current

Noncurrent Liabilities

Other Liabilities Noncurrent

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInInvestingActivities

Payments To Acquire Property Plant And Equipment

Shares

Weighted Average Number Of Diluted Shares Outstanding

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Interest Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Due Year Four

Line plots across dimensions of each concept

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'mrsn:CollaborationAndCommercialLicenseAgreementAsanaBioSciences')

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)

Allocated Share Based Compensation Expenseus-gaap: Award Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)

Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'mrsn:CollaborationAndCommercialLicenseAgreementAsanaBioSciences')

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party